Cargando…

Management of severe hyperinflammation in the COVID-19 era: the role of the rheumatologist

OBJECTIVES: The objectives of this study were (i) to describe the clinical presentation, treatment and outcome of paediatric inflammatory multisystem syndrome temporally related to Sars-CoV-2 (PIMS-TS) in children; (ii) to propose a framework to guide multidisciplinary team (MDT) management; and (ii...

Descripción completa

Detalles Bibliográficos
Autores principales:	Papadopoulou, Charalampia, Al Obaidi, Muthana, Moraitis, Elena, Compeyrot-Lacassagne, Sandrine , Eleftheriou, Despina, Brogan, Paul
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2020
Materias:	Clinical Science
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7717388/ https://www.ncbi.nlm.nih.gov/pubmed/33197261 http://dx.doi.org/10.1093/rheumatology/keaa652

Ejemplares similares

OA05 Clinical presentation, risk factors and prognosis of MDA5-positive JDM; clinical diversity and red flags
por: McLellan, Kirsty, et al.
Publicado: (2022)

Identification and prediction of novel classes of long-term disease trajectories for patients with juvenile dermatomyositis using growth mixture models
por: Deakin, Claire T, et al.
Publicado: (2020)

Janus kinase 1/2 inhibition with baricitinib in the treatment of juvenile dermatomyositis
por: Papadopoulou, Charalampia, et al.
Publicado: (2019)

The Performance of Quantiferon TB Gold In-Tube as a Screening Tool in Paediatric Rheumatology prior to Initiation of Infliximab: A Single Centre's Experience
por: Maritsi, Despoina, et al.
Publicado: (2011)

Takayasu arteritis in childhood: retrospective experience from a tertiary referral centre in the United Kingdom
por: Eleftheriou, Despina, et al.
Publicado: (2015)

Successful use of ofatumumab in two cases of early-onset juvenile SLE with thrombocytopenia caused by a mutation in protein kinase C δ
por: Lei, Linda, et al.
Publicado: (2018)

Systemic juvenile idiopathic arthritis: The Great Ormond Street Hospital experience (2005–2021)
por: Foley, C. M., et al.
Publicado: (2023)

Juvenile arthritis disease activity score is a better reflector of active disease than the disease activity score 28 in adults with polyarticular juvenile idiopathic arthritis
por: Wu, Qiong, et al.
Publicado: (2016)

Magnetic resonance imaging findings in children with Parry-Romberg syndrome and en coup de sabre
por: Knights, Harry, et al.
Publicado: (2021)

US rheumatologists’ beliefs and knowledge about biosimilars: a survey
por: Gibofsky, Allan, et al.
Publicado: (2020)

Rheumatologists in the COVID-19 era: will there be a new role for the rheumatologist in the care of rheumatic patients?
por: Morales-Torres, Jorge, et al.
Publicado: (2020)

P41 Spotting the needle amongst the haystack - when asthma isn’t asthma
por: Jashmi, Ruqaiya Al, et al.
Publicado: (2022)

Pediatric uveitis: Role of the pediatrician
por: Shivpuri, Abhay, et al.
Publicado: (2022)

Management of hyperinflammation in COVID-19 patients
por: Suberviola, Borja, et al.
Publicado: (2022)

Evaluation of magnetic resonance imaging abnormalities in juvenile onset neuropsychiatric systemic lupus erythematosus
por: Al-Obaidi, M, et al.
Publicado: (2016)

What is the role of rheumatologists in the era of COVID-19?
por: Marotto, Daniela, et al.
Publicado: (2020)

Microparticle-mediated VZV propagation and endothelial activation: Mechanism of VZV vasculopathy
por: Eleftheriou, Despina, et al.
Publicado: (2020)

Vision transformer assisting rheumatologists in screening for capillaroscopy changes in systemic sclerosis: an artificial intelligence model
por: Garaiman, Alexandru, et al.
Publicado: (2022)

JAK inhibitors: a potential treatment for JDM in the context of the role of interferon-driven pathology
por: Ll Wilkinson, Meredyth G., et al.
Publicado: (2021)

Vasculitis update: pathogenesis and biomarkers
por: Brogan, Paul, et al.
Publicado: (2017)

Nailfold capillaroscopy: a survey of current UK practice and ‘next steps’ to increase uptake among rheumatologists
por: Eden, Martin, et al.
Publicado: (2022)

Paediatric rheumatologists do not score the physician’s global assessment of juvenile idiopathic arthritis disease activity in the same way
por: Backström, Maria, et al.
Publicado: (2023)

Management of Patients With Inflammatory Rheumatic Diseases: Telemedicine and Rheumatologists Challenged in the Era of COVID-19
por: Foti, Rosario, et al.
Publicado: (2020)

Therapeutic advances in the treatment of vasculitis
por: Eleftheriou, Despina, et al.
Publicado: (2016)

Vasculitis in children
por: Eleftheriou, Despina, et al.
Publicado: (2009)

The Molecular Biology and Treatment of Systemic Vasculitis in Children
por: Eleftheriou, Despina, et al.
Publicado: (2012)

Multinational evidence-based recommendations for pain management by pharmacotherapy in inflammatory arthritis: integrating systematic literature research and expert opinion of a broad panel of rheumatologists in the 3e Initiative
por: Whittle, Samuel L., et al.
Publicado: (2012)

Attitude of Iraqi Rheumatologists While Managing Rheumatic Diseases in the Era of COVID-19: An Online Survey
por: Jassim, Nizar Abdulateef, et al.
Publicado: (2020)

Small vessel vasculitis
por: Brogan, Paul, et al.
Publicado: (2009)

P47 The conundrums of Macrophage activation syndrome (MAS) - when to consider a Haematopoietic Stem Cell Transplant (HSCT)
por: Gallagher, Kathy, et al.
Publicado: (2022)

Hyperinflammation, T cells, and endotoxemia
por: Inoue, Makoto, et al.
Publicado: (2015)

Lentiviral Mediated ADA2 Gene Transfer Corrects the Defects Associated With Deficiency of Adenosine Deaminase Type 2
por: Hong, Ying, et al.
Publicado: (2022)

Can rheumatologists diagnose and manage Giant Cell Arteritis better than non-rheumatologists? The Maltese Experience
por: Cefai, Erika, et al.
Publicado: (2017)

A nanotrap improves survival in severe sepsis by attenuating hyperinflammation
por: Shi, Changying, et al.
Publicado: (2020)

Testicular ischemia in deficiency of adenosine deaminase 2 (DADA2)
por: Clarke, Katherine, et al.
Publicado: (2019)

Rheumatoid Hand Surgery in the Era of Biologic Therapy: A Rheumatologist-oriented Overview
por: Park, Jin Woo, et al.
Publicado: (2021)

Immunopathology of Hyperinflammation in COVID-19
por: Gustine, Joshua N., et al.
Publicado: (2021)

Medium-size-vessel vasculitis
por: Dillon, Michael J., et al.
Publicado: (2009)

Diversity in clinical manifestations of autoinflammatory syndromes
por: Boiu, S, et al.
Publicado: (2011)

Progressive neurologic disorder: Initial manifestation of hemophagocytic lymphohistiocytosis
por: Murphy, Claire, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_imufggo5qs7et83hi3lmi187hk